American College of Cardiology/American Heart Association (ACC/AHA) class I guidelines for the treatment of cholesterol to reduce atherosclerotic cardiovascular risk: Implications for US Hispanics/Latinos based on findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Journal of the American Heart Association

Volumn 6, Issue 5, 2017, Pages

  Qureshi, Waqas T ^a   Kaplan, Robert C ^b   Swett, Katrina ^a   Burke, Gregory ^b   Daviglus, Martha ^c   Jung, Molly ^d   Talavera, Gregory A ^e   Chirinos, Diana A ^f   Reina, Samantha A ^f   Davis, Sonia ^g   Rodriguez, Carlos J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e SAN DIEGO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

ACC AHA cholesterol treatment; Disparities; Epidemiology; Guideline; Hispanics Latinos; Statin therapy

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; CHOLESTEROL;

AMERICAN; ARTICLE; BLACK PERSON; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY STENTING; CENTRAL AMERICAN; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CUBAN; DIABETES MELLITUS; DOMINICAN (DOMINICA); EDUCATION; FEMALE; HEART INFARCTION; HISPANIC; HUMAN; HYPERTENSION; INCOME; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OBESITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUERTO RICAN; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; BLOOD; CARDIOLOGY; CLINICAL DECISION MAKING; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; ETHNOLOGY; HEALTH CARE DISPARITY; MIDDLE AGED; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; STANDARDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMERICAN HEART ASSOCIATION; ATHEROSCLEROSIS; BIOMARKERS; CARDIOLOGY; CHOLESTEROL; CLINICAL DECISION-MAKING; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; ELIGIBILITY DETERMINATION; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 85019385350     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.005045     Document Type: Article

References (32)

1. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Tomaselli GF. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49-S73.
2. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143-3421.
3. Pencina MJ, Navar-Boggan AM, D'Agostino RB Sr, Williams K, Neely B, Sniderman AD, Peterson ED. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370:1422-1431.
4. Bonilla C, Parra EJ, Pfaff CL, Dios S, Marshall JA, Hamman RF, Ferrell RE, Hoggart CL, McKeigue PM, Shriver MD. Admixture in the Hispanics of the San Luis Valley, Colorado, and its implications for complex trait gene mapping. Ann Hum Genet. 2004;68:139-153.
5. Bonilla C, Shriver MD, Parra EJ, Jones A, Fernandez JR. Ancestral proportions and their association with skin pigmentation and bone mineral density in Puerto Rican women from New York City. Hum Genet. 2004;115:57-68.
6. Manichaikul A, Palmas W, Rodriguez CJ, Peralta CA, Divers J, Guo X, Chen WM, Wong Q, Williams K, Kerr KF, Taylor KD, Tsai MY, Goodarzi MO, Sale MM, Diez-Roux AV, Rich SS, Rotter JI, Mychaleckyj JC. Population structure of Hispanics in the United States: the Multi-Ethnic Study of Atherosclerosis. PLoS Genet. 2012;8:e1002640.
7. Conomos MP, Laurie CA, Stilp AM, Gogarten SM, McHugh CP, Nelson SC, Sofer T, Fernandez-Rhodes L, Justice AE, Graff M, Young KL, Seyerle AA, Avery CL, Taylor KD, Rotter JI, Talavera GA, Daviglus ML, Wassertheil-Smoller S, Schneiderman N, Heiss G, Kaplan RC, Franceschini N, Reiner AP, Shaffer JR, Barr RG, Kerr KF, Browning SR, Browning BL, Weir BS, Aviles-Santa ML, Papanicolaou GJ, Lumley T, Szpiro AA, North KE, Rice K, Thornton TA, Laurie CC. Genetic diversity and association studies in US Hispanic/Latino populations: applications in the Hispanic Community Health Study/Study of Latinos. Am J Hum Genet. 2016;98:165-184.
8. Sorlie PD, Aviles-Santa LM, Wassertheil-Smoller S, Kaplan RC, Daviglus ML, Giachello AL, Schneiderman N, Raij L, Talavera G, Allison M, Lavange L, Chambless LE, Heiss G. Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010;20:629-641.
9. Lavange LM, Kalsbeek WD, Sorlie PD, Aviles-Santa LM, Kaplan RC, Barnhart J, Liu K, Giachello A, Lee DJ, Ryan J, Criqui MH, Elder JP. Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010;20:642-649.
10. Daviglus ML, Talavera GA, Aviles-Santa ML, Allison M, Cai J, Criqui MH, Gellman M, Giachello AL, Gouskova N, Kaplan RC, LaVange L, Penedo F, Perreira K, Pirzada A, Schneiderman N, Wassertheil-Smoller S, Sorlie PD, Stamler J. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308:1775-1784.
11. Rodriguez CJ, Daviglus ML, Swett K, Gonzalez HM, Gallo LC, Wassertheil-Smoller S, Giachello AL, Teng Y, Schneiderman N, Talavera GA, Kaplan RC. Dyslipidemia patterns among Hispanics/Latinos of diverse background in the United States. Am J Med. 2014;127:1186-1194.e1181.
12. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
13. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Tomaselli GF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-S45.
14. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2935-2959.
15. Cochran WG. Sampling Techniques. New York: John Wiley & Sons; 2007.
16. Pursnani A, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Hoffmann U. Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events. JAMA. 2015;314:134-141.
17. Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, Ikram MA, Stricker BH, Hofman A, Franco OH. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311:1416-1423.
18. Wong ND, Young D, Zhao Y, Nguyen H, Caballes J, Khan I, Sanchez RJ. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012. J Clin Lipidol. 2016;10:1109-1118.
19. Kim NH, So MS, Kang JG, Cho DS, Byrne CD, Lee SJ, Sung KC. Application of new guidelines for the primary prevention of atherosclerotic cardiovascular disease in a Korean population. J Atheroscler Thromb. 2015;22:293-303.
20. Jung CH, Lee MJ, Kang YM, Yang DH, Kang JW, Kim EH, Park DW, Park JY, Kim HK, Lee WJ. 2013 ACC/AHA versus 2004 NECP ATP III guidelines in the assignment of statin treatment in a Korean population with subclinical coronary atherosclerosis. PLoS One. 2015;10:e0137478.
21. Echeverría G, Dussaillant C, Villarroel L, Rigotti A. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile. J Clin Lipidol. 2016;10:192-198.e191.
22. Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2015;169:387-395.e383.
23. Ruiz JM, Steffen P, Smith TB. Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. Am J Public Health. 2013;103: e52-e60.
24. Cortes-Bergoderi M, Goel K, Murad MH, Allison T, Somers VK, Erwin PJ, Sochor O, Lopez-Jimenez F. Cardiovascular mortality in Hispanics compared to non-Hispanic whites: a systematic review and meta-analysis of the Hispanic paradox. Eur J Intern Med. 2013;24:791-799.
25. Borrell LN, Lancet EA. Race/ethnicity and all-cause mortality in US adults: revisiting the Hispanic paradox. Am J Public Health. 2012;102:836-843.
26. Smith DP, Bradshaw BS. Rethinking the Hispanic paradox: death rates and life expectancy for US non-Hispanic White and Hispanic populations. Am J Public Health. 2006;96:1686-1692.
27. Rana JS, Tabada GH, Solomon MD, Lo JC, Jaffe MG, Sung SH, Ballantyne CM, Go AS. Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population. J Am Coll Cardiol. 2016;67:2118-2130.
28. Blaha MJ. The critical importance of risk score calibration: time for transformative approach to risk score validation? J Am Coll Cardiol. 2016;67:2131-2134.
29. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279:1458-1462.
30. Kulik A, Shrank WH, Levin R, Choudhry NK. Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization. Am J Cardiol. 2011;107:1409-1414.
31. Applegate WB. Elderly patients' adherence to statin therapy. JAMA. 2002;288:495-497.
32. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462-467.